Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours

Clinical trial NCT05752552 · RECRUITING

Trial details

NCT number: NCT05752552
Sponsor: DeuterOncology
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Adult Solid Tumor Advanced Solid Tumor Refractory Tumor Non-small Cell Lung Cancer Non-small Cell Carcinoma Lung Cancer Hereditary Renal Papillary Cancer

Start date: 2022-12-20
Primary completion: 2027-09-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.